COVARYX

Product NDC
11528-010
Requested package NDC
11528-010-01
11-digit product format
115280010
Labeler code
11528
Product ID
11528-010_9d03bf4c-e54a-795d-e053-2a95a90a9e02
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ESTROGENS, ESTERIFIED and METHYLTESTOSTERONE
Dosage form
TABLET, COATED
Route
ORAL
Labeler
CENTRIX PHARMACEUTICAL, INC,
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2007-04-01
Marketing end
0000-00-00
Substance
ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE
Active strength
1 mg/1; mg/1
Pharmacologic classes
Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [CS]
DEA schedule
CIII
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage11528-01011528-010-01IInactivated by FDA2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-288af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-081332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29fb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-0886f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01bd6a592717d7…303034d00443…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9d0e3d5e-5fb0-9833-ff7c-640f05e449aeProduct name420230314
aaaf3f1f-0ca7-2c75-a463-4dc624538feeProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
11528-010-012022-01-28C16284748780-1d6a99b39-86fb-a426-e053-dadaa90af4c2COVARYX

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11528-010-01COVARYX100 in 1 BOTTLE, PLASTICTABLET, COATED1002

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
11528-010-01EA - Each11528-010337bc91a-9b99-42ec-adde-08a990f2a87612013-03-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ESTROGENS, ESTERIFIEDACTIVE INGREDIENT3ASP8Q3768COVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
METHYLTESTOSTERONEACTIVE INGREDIENTV9EFU16ZIFCOVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
ESTROGENS, ESTERIFIEDACTIVE MOIETY3ASP8Q3768COVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
METHYLTESTOSTERONEACTIVE MOIETYV9EFU16ZIFCOVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933COVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UCOVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
D&C RED NO. 30INACTIVE INGREDIENT2S42T2808BCOVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
FD&C YELLOW NO. 5INACTIVE INGREDIENTI753WB2F1MCOVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8COVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
LACTOSEINACTIVE INGREDIENTJ2B2A4N98GCOVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30COVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1ACOVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
POLYVINYL ALCOHOLINACTIVE INGREDIENT532B59J990COVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4COVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
SODIUM BICARBONATEINACTIVE INGREDIENT8MDF5V39QOCOVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULRCOVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
TALCINACTIVE INGREDIENT7SEV7J4R1UCOVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPCOVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11528-010COVARYX HS (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED COVARYX (ESTROGENS, ESTERIFIED AND METHYLTESTOSTERONE) TABLET, COATED [CENTRIX PHARMACEUTICAL, INC,]2Legacy NDC, 1 package rows20200128_e4ff7b6b-ce78-402c-9c0e-b8b0d9636eae.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
705919Covaryx 1.25 MG / 2.5 MG Oral TabletPSNe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2
705921Covaryx HS 0.625 MG / 1.25 MG Oral TabletPSNe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2
238006estrogens, esterified 0.625 MG / methylTESTOSTERone 1.25 MG Oral TabletPSNe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2
197670estrogens, esterified 1.25 MG / methylTESTOSTERone 2.5 MG Oral TabletPSNe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2
705921estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet [Covaryx]SBDe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2
705919estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG Oral Tablet [Covaryx]SBDe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2
238006estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral TabletSCDe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2
197670estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG Oral TabletSCDe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2
705921Covaryx (estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG) Oral TabletSYe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2
705919Covaryx (estrogens, esterified (USP) 1.25 MG / methyltestosterone 2.5 MG) Oral TabletSYe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2
705921Covaryx HS (estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG) Oral TabletSYe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2
197670EEMT DS Oral TabletSYe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2
238006EEMT HS Oral TabletSYe4ff7b6b-ce78-402c-9c0e-b8b0d9636eae2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
11528-010-0111528001001100 TABLET, COATED in 1 BOTTLE, PLASTIC (11528-010-01) 2007-04-010000-00-00NoNoCurrent